**Europe’s Mental Health Support:** A study by the Economist Intelligence Unit, sponsored by Janssen Pharmaceutica NV, found that 38% of Europeans suffer from mental illness annually. The report, "Mental Health Integration – Provision for Supporting People With Mental Illness: A Comparison of 30 European Countries," highlights issues such as silo thinking, lack of integrated support, and insufficient funding. Key areas for improvement include research, funding, deinstitutionalization, and community-based services. **No Health Without Mental Health:** Research from Emory University shows that mental illness is associated with a 2.22 times higher risk of death compared to the general population. About 14.3% of global deaths, or 8 million annually, are attributed to mental disorders. The study emphasizes the need for better prevention and management of comorbidities with physical conditions. **Sestrin 3 and Epilepsy:** Researchers at Imperial College London used systems genetics to identify Sestrin 3 (SESN3) as a regulator of a gene network involved in epilepsy. This discovery could lead to more effective anti-epileptic drugs and potentially benefit other brain conditions like Alzheimer's and neurodevelopmental disorders. **Chronic Undernourishment:** According to the UN Food and Agriculture Organization, 805 million people, or one in nine globally, are chronically undernourished. Most of these individuals live in low- and middle-income countries, but even high-income countries have 11 million undernourished people. Poverty is a major factor in undernourishment. **Insomnia:** Insomnia is a common condition that is challenging to treat and burdensome for patients. Traditional hypnotics often cause tolerance and dependence. Scientists at Imperial College London have discovered that specific neurons in the preoptic hypothalamus are crucial for inducing sleep. Targeting these neurons could lead to more natural and less dependent sleep-inducing drugs.**Europe’s Mental Health Support:** A study by the Economist Intelligence Unit, sponsored by Janssen Pharmaceutica NV, found that 38% of Europeans suffer from mental illness annually. The report, "Mental Health Integration – Provision for Supporting People With Mental Illness: A Comparison of 30 European Countries," highlights issues such as silo thinking, lack of integrated support, and insufficient funding. Key areas for improvement include research, funding, deinstitutionalization, and community-based services. **No Health Without Mental Health:** Research from Emory University shows that mental illness is associated with a 2.22 times higher risk of death compared to the general population. About 14.3% of global deaths, or 8 million annually, are attributed to mental disorders. The study emphasizes the need for better prevention and management of comorbidities with physical conditions. **Sestrin 3 and Epilepsy:** Researchers at Imperial College London used systems genetics to identify Sestrin 3 (SESN3) as a regulator of a gene network involved in epilepsy. This discovery could lead to more effective anti-epileptic drugs and potentially benefit other brain conditions like Alzheimer's and neurodevelopmental disorders. **Chronic Undernourishment:** According to the UN Food and Agriculture Organization, 805 million people, or one in nine globally, are chronically undernourished. Most of these individuals live in low- and middle-income countries, but even high-income countries have 11 million undernourished people. Poverty is a major factor in undernourishment. **Insomnia:** Insomnia is a common condition that is challenging to treat and burdensome for patients. Traditional hypnotics often cause tolerance and dependence. Scientists at Imperial College London have discovered that specific neurons in the preoptic hypothalamus are crucial for inducing sleep. Targeting these neurons could lead to more natural and less dependent sleep-inducing drugs.